Mercado Global de Testes Hereditários – Tendências do Setor e Previsão para 2029

Análise e dimensão do mercado de testes hereditários

Prevê-se que o mercado dos testes hereditários se expanda significativamente nos próximos anos devido ao aumento do cancro e das doenças genéticas, bem como ao aumento do conhecimento e aceitação da terapia personalizada. A farmacogenómica, muitas vezes conhecida como teste genético de drogas, tem utilizado frequentemente testes hereditários. Prevê-se que as melhorias nos métodos de testes genéticos acelerem a expansão do mercado.

A Data Bridge Market Research analisa que o mercado de testes hereditários, que foi de 1,90 mil milhões de dólares em 2021, dispararia para 3,83 mil milhões de dólares até 2029, e deverá passar por um CAGR de 9,15% durante o período de previsão de 2022 a 2029. Além dos insights de mercado, tais como o valor de mercado, a taxa de crescimento, os segmentos de mercado, a cobertura geográfica, os participantes do mercado e o cenário de mercado, o relatório de mercado com curadoria da equipa de pesquisa de mercado da Data Bridge inclui também análise especializada aprofundada, epidemiologia do paciente, análise de pipeline, análise de preços e quadro regulamentar.

Âmbito e segmentação do mercado de testes hereditários

Definição de mercado

Nos testes hereditários, as variações hereditárias específicas (variantes) nos genes de uma pessoa são alteradas. Sobre a probabilidade de contrair doenças, as variações genéticas podem ter efeitos negativos, positivos, neutros (sem efeito) ou ambíguos. Existem evidências de que certos genes com mutações prejudiciais aumentam a probabilidade de adquirir cancro. Estima-se que 5 a 10% de todas as doenças malignas são causadas por estas variações hereditárias.

Dinâmica do mercado de ensaios hereditários

Motoristas

• Aumento da prevalência de cancro hereditário

O cancro é uma doença genética causada por alterações específicas nos genes que controlam a eficácia das células, afetando principalmente o seu crescimento e duplicação. As mutações genéticas hereditárias são a causa de cerca de 5–10% de todos os cancros. Os detetives relacionaram mutações em genes específicos com outras 50 síndromes de cancro hereditário que afetam entidades emergentes de certos tipos de cancro.

• Desenvolvimento em tecnologia genómica

O cancro da mama é um dos cancros mais colectivos do mundo, afectando quase 12,5% das mulheres durante a vida e 5% a 10% destes doentes têm uma forma hereditária. Os genes BRCA1 e BRCA2 são os dois genes com mutação mais mútua, mas estão a surgir genes adicionais ligados ao cancro da mama hereditário. Novos desenvolvimentos nas competências genómicas direcionaram testes paralelos de múltiplos genes.

Oportunidades

A mutação nos genes é um fator que impacta a deteção precoce do cancro hereditário, aumentando o crescimento do mercado. Ao mesmo tempo, a eficácia e a relação custo-benefício em relação aos métodos de teste tradicionais também impulsionam o crescimento do mercado. Além disso, a crescente procura por descoberta inicial e análise precisa é uma característica que impulsiona o crescimento do mercado.

Restrições/Desafios

O desempenho dos testes de painel multigénico hereditário levanta diversas questões, como as medidas que os doentes devem cumprir para realizar o teste e a associação clínica do doente, o que irá obstruir o crescimento do mercado.

This hereditary testing  market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hereditary testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Hereditary Testing Market

Many of the industries across the world have been harmfully wedged over the last 18 months. This can be attributed to significant disturbances experienced by their respective industrialized and supply-chain processes as a result of various precautionary lockdowns and other restrictions governing establishments across the globe enforced. Furthermore, consumer demand has also subsequently reduced as persons are now more keen on eradicating non-essential expenses from their respective budgets. Most persons' general economic status has been severely affected by this outbreak. These aforementioned elements are predictable to burden the revenue trajectory of the global hereditary testing market over the forecast timeline.

Recent Development

• In June 2020, Invitae and ArcherDX announced Monday morning that the two genetic testing companies have agreed to syndicate in command to expand their footmark in the cancer genetics and precision oncology space.

Global Hereditary Testing Market Scope

The hereditary testing market is segmented on the basis of type, indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

 Type

• Multi Panel Test
• Single-site Genetic Test

Indication

• Breast Cancer
• Ovarian Cancer
• Colorectal Cancer
• Others

End-user

• Diagnostic Laboratory
• Hospitals
• Others

Hereditary Testing Market Regional Analysis/Insights

The hereditary testing market is analysed and market size insights and trends are provided by country, type, indication and end user as referenced above.

The countries covered in the hereditary testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America, the market is dominates the market owing to rising throwaway revenue, availability of advanced healthcare infrastructure, and increasing adoption of genetic testing in the region.

Asia-Pacific and Europe are expected to a significant growth rate in the coming years due to growing cancer cases and developing healthcare sectors.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The hereditary testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hereditary testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hereditary testing market. The data is available for historic period 2010-2020.

Competitive Landscape and Hereditary Testing Market Share Analysis

The hereditary testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to hereditary testing market.

Some of the major players operating in the hereditary testing market are:

• CENTOGENE N.V. ( Germany)
• Ambry Genetics (U.S.)
• Myriad Genetics, Inc.  (U.S.)
• NeoGenomics Laboratories (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• PreventionGenetics (U.S.)
• Fulgent Genetics (U.S.)
• Invitae Corporation (U.S.)
• Laboratórios de Diagnóstico Médico, LLC (EUA)
• Natera (EUA)
• Caris Life Sciences (EUA)
• LabSolutions (EUA)
• (EUA)
• Laboratórios ARUP (EUA)

SKU-53007